Methadone analgesia in morphine-insensitive CXBK mice

European Journal of Pharmacology

Volumn 351, Issue 2, 1998, Pages 189-191

  Chang, Albert ^a   Emmel, David W ^a   Rossi, Grace C ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Opioid receptor; Analgesia; Morphine; Strain

Indexed keywords

BETA FUNALTREXAMINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; DRUG RESISTANCE; MALE; METHADONE; MICE; MORPHINE;

EID: 0031837862     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00366-5     Document Type: Article

References (22)

1. Baron, A., Shuster, L., Elefterhiou, B.E., Bailey, D.W., 1975. Opiate receptors in mice: genetic differences. Life Sci. 17, 633-640.
2. Bouvier, C., Unteutsch, A., Hagen, S., Zhu, W.Z., Bunzow, J.R., Grandy, D.K., 1994. Agonist properties of methadone at the cloned rat μ opioid receptor. Regul. Pept. 54, 31-32.
3. Brown, G.P., Yang, K., King, M.A., Rossi, G.C., Leventhal, L., Chang, A., Pasternak, G.W., 1997. 3-Methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist. FEBS Lett. 412, 35-38.
4. Dole, V.P., 1988. Implications of methadone maintenance for theories of narcotic addiction. J. Am. Med. Assoc. 260, 3025-3029.
5. Irwin, S., Houde, R.W., Bennett, D.R., Hendershot, L.C., Seevers, M.H., 1951. The effects of morphine, methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther. 101, 132-143.
6. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56, PL45-PL50.
7. Ling, G.S.F., Tappe, N.S., Inturrisi, C.E., 1984. Methadone induced physical dependence in the rat. Life Sci. 34, 683-690.
8. 2, and delta opioid binding in the central nervous of C57BL/6BY and CXBK (opioid receptor-deficient) mice. Brain Res. 360, 108-116.
9. Pasternak, G.W., 1993. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16, 1-18.
10. Pasternak, G.W., Standifer, K.M., 1995. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16, 344-350.
11. Pasternak, G.W., Bodnar, R.J., Clark, J.A., Inturrisi, C.E., 1987. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 41, 2845-2849.
12. Paul, D., Standifer, K.M., Inturrisi, C.E., Pasternak, G.W., 1989. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J. Pharmacol. Exp. Ther. 251, 477-483.
13. Pick, C.G., Nejat, R., Pasternak, G.W., 1993. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains. J. Pharmacol. Exp. Ther. 2265, 166-171.
14. Reith, M.E.A., Sershen, H., Vadasz, C., Lajtha, A., 1981. Strain differences in opiate receptors in mouse brain. Eur. J. Pharmacol. 74, 377-380.
15. Rossi, G.C., Pan, Y.-X., Brown, G.P., Pasternak, G.W., 1995a. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6β-glucuronide receptor. FEBS Lett. 369, 192-196.
16. Rossi, G.C., Standifer, K.M., Pasternak, G.W., 1995b. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci. Lett. 198, 99-102.
17. Rossi, G.C., Brown, G.P., Leventhal, L., Yang, K., Pasternak, G.W., 1996. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci. Lett. 216, 1-4.
18. Rossi, G.C., Leventhal, L., Pan, Y.X., Cole, J., Su, W., Bodnar, R.J., Pasternak, G.W., 1997. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6β-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281, 109-114.
19. Tallarida, R.J., Murray, R.B., 1987. Manual of Pharmacological Calculations with Computer Programs. Springer, New York, p. 153.
20. Vaught, J.L., Mathiasen, J.H.R., Raffa, R.B., 1988. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. J. Pharmacol. Exp. Ther. 245, 12-16.
21. Ward, S.J., Portoghese, P.S., Takemori, A.E., 1982a. Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J. Pharmacol. Exp. Ther. 220, 494-498.
22. Ward, S.J., Portoghese, P.S., Takemori, A.E., 1982b. Pharmacological profiles of β-funaltrexamine (β-FNA) and β-chlornaltrexamine (β-CNA) on the mouse vas deferens preparation. Eur. J. Pharmacol. 80, 377-384.